Home DailyMed 8736ecd8-fa0b-9c47-e053-2991aa0a493c NIACINAMIDE 4% / TRETINOIN 0.025% Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer Sincerus Florida, LLC
Effective date 2019-04-23
Label type HUMAN PRESCRIPTION DRUG LABEL
Version 1
Source full-release
Hydrated at 2026-05-31 20:28:24 Label at a glance# Product NIACINAMIDE 4% / TRETINOIN 0.025%
Active ingredient TRETINOIN, NIACINAMIDE
Label structure 4 sections
DailyMed Pharmacologic Classes# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72934-1162-2 NIACINAMIDE 4% / TRETINOIN 0.025% 30 g in 1 BOTTLE, PUMP GEL 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72934-1162 NIACINAMIDE 4% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA, LLC] 1 Legacy NDC, 1 package rows 20190501_8736ecd8-fa0b-9c47-e053-2991aa0a493c.zip
Products# Every source-derived product name is available through these pages.
DailyMed product names page 1 of 1 · 3 matching rows.
NIACINAMIDE 4% / TRETINOIN 0.025% TRETINOIN NIACINAMIDE Ingredients# Every source-derived ingredient row is available through these pages.
DailyMed ingredient rows page 1 of 1 · 2 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.